Optimization of the 4-aryl group of 4-aryl-pyridine glucagon antagonists: Development of an efficient, alternative synthesis

Bioorganic and Medicinal Chemistry Letters

Volumn 12, Issue 9, 2002, Pages 1303-1306

  Smith, Roger A ^a   Hertzog, Donald L ^a   Osterhout, Martin H ^a   Ladouceur, Gaetan H ^a   Korpusik, Mary ^a   Bobko, Mark A ^a   Jones, J Howard ^a   Phelan, Kathleen ^a   Romero, Romulo H ^a   Hundertmark, Thomas ^a   MacDougall, Margit L ^a   Livingston, James N ^a   Schoen, William R ^a  

^a BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCAGON ANTAGONIST; PHENYLPYRIDINE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; DRUG ACTIVITY; DRUG SYNTHESIS; DRUG TOLERANCE; IC 50; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

GLUCAGON; PYRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 18344379308     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00143-9     Document Type: Article

References (26)